2.14.3 NEURORESTORATIVE, NEUROPROTECTIVE AND CELL CYCLE ARREST ACTIVITY OF NOVEL MULTI TARGET DRUGS IN ANIMAL MODELS OF PARKINSON'S DISEASE von Youdim, M.B.H

Volltext

Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain von Kupershmidt, L, Weinreb, O, Amit, T, Mandel, S, Bar-Am, O, Youdim, M.B.H

Volltext

Multimodal neuroprotective–neurorestorative drugs acting on the mitochondria for treatment of Alzheimer's disease von Youdim, M.B.H

Volltext

PL.01.01 Multi-target neuroprotective–neurorestorative drugs for Alzheimer's disease von Youdim, M.B.H, Mandel, S, Weinreb, O, Amit, T, Kupershmidt, L

Volltext

Influence of neuromelanin on oxidative pathways within the human substantia nigra von Double, K.L, Ben-Shachar, D, Youdim, M.B.H, Zecca, L, Riederer, P, Gerlach, M

Volltext

P3.118 Silencing/over-expressing selected genes as a novel model of sporadic Parkinson's disease von Fishman-Jacob, T, Youdim, M.B.H, Mandel, S

Volltext

Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease von Youdim, M.B.H, Tipton, K.F

Volltext

MAO-B inhibitors: multiple roles in the therapy of neurodegenerative disorders? von Foley, P., Gerlach, M., Youdim, M.B.H., Riederer, P.

Volltext

Genomic aspects of sporadic Parkinson's disease von Riederer, P, Youdim, M.B.H, Mandel, S, Gerlach, M, Grünblatt, E

Volltext

2.426 Mechanism of degradation of Bad protein by the green tea polyphenol (−)-epigallocatechin-3-gallate: Implication for neuroprotection von Kalfon, L, Mandel, S.A, Youdim, M.B.H

Volltext

2.401 Silencing plus over expression of selected genes as a novel model of sporadic Parkinson's disease von Fishman, T, Youdim, M.B.H, Mandel, S

Volltext

2.021 Regulation of the iron-responsive proteins amyloid precursor protein and alpha-synuclein by green tea polyphenol (−)-epigallocatechin-3-gallate von Reznichenko, L, Amit, T, Weinreb, O, Youdim, M.B.H, Mandel, S.A

Volltext

2.317 Regulation of the iron-responsive proteins amyloid precursor protein and alpha-synuclein by green tea polyphenol (−)-epigallocatechin-3-gallate von Reznichenko, L, Amit, T, Weinreb, O, Youdim, M.B.H, Mandel, S.A

Volltext

1.100 Early diagnosis for Parkinson's disease according to whole blood gene profile von Grünblatt, E, Mandel, S, Müller, T, Jost, W.H, Youdim, M.B.H, Riederer, P.F

Volltext

1.011 Early diagnosis for Parkinson's disease according to whole blood gene profile von Grünblatt, E, Mandel, S, Müller, T, Jost, W.H, Youdim, M.B.H, Riederer, P.F

Volltext

IV.17 Future developments in the treatment of Parkinson's Disease: a case for multifunctional drugs von Youdim, M.B.H.

Volltext

Neuroprotective strategies in Parkinson's disease: An update on progress von MANDEL, Silvia, GRÜNBLATT, Edna, RIEDERER, Peter, GERLACH, Manfred, LEVITES, Yona, YOUDIM, Moussa B. H

Volltext

Pharmacology of selegiline von Gerlach, M, Youdim, M B, Riederer, P

Volltext

Enhancing effect of rasagiline on superoxide dismutase and catalase activities in the dopaminergic system in the rat von Carrillo, M.C., Minami, C., Kitani, K., Maruyama, W., Ohashi, K., Yamamoto, T., Naoi, M., Kanai, S., Youdim, M.B.H.

Volltext

Therapeutic potentials for reversible MAOA and MAOB inhibitors in the clinic von Youdim, M.B.H.

Volltext